ValueAct Capital
step operational review of eleven outside of japan a | ValueAct Capital
Company
Deck Type
Sector
Industry
Deck date
February 2022
Slide
34 of 75
Related slides by other companies
Ocuphire Pharma
Investor Presentation
November 2023
corporate highlights | Ocuphire Pharma
Metals Acquisition Corp
SPAC
March 2022
potential to extend mine life through resource delineation multiple areas of near mine resources potential identified with of drilling excluded from current resource rant ars upper exploration target | Metals Acquisition Corp
Freshpet
Results
February 2025
updated targets billion | Freshpet
Chimerix
Investor Presentation
August 2023
agonist distinct molecular target and efficacy profile relative to efficacy in preclinical models of advanced cancers tox studies complete potential to advance to partnerships established for early stage clinical trials with brown university and cancer center preclinical studies are ongoing to evaluate additional oncology indications and predictive for for clinical development pancreatic cancer model shows the potential of | Chimerix
Other recent decks by ValueAct Capital
See all presentations (2 decks)
Activist
March 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights